Aragen Life Sciences

Aragen Life Sciences is a leading Asia-based life sciences research and development provider offering end-to-end discovery and development services across the R&D and manufacturing value chain. The company specializes in drug discovery, clinical development, contract manufacturing, formulation, and informatics, enabling pharmaceutical, biotechnology, and healthcare organizations to advance therapies. With a team of scientists and established processes, Aragen emphasizes speed, quality, and cost efficiency to help global customers translate research into medicines and healthcare products.

Sudhir Kumar Singh

COO

3 past transactions

Intox

Acquisition in 2021
Intox provides comprehensive non-clinical research services, including in-vivo and in-vitro studies, catering to diverse industries such as pharmaceuticals, biopharmaceuticals, plant protection, nutraceuticals, and medical devices. The company offers a broad range of safety assessment studies to meet clients' research and testing service needs.

Vanta Bioscience

Acquisition in 2014
Vanta Bioscience is a preclinical contract research organization offering non-clinical safety assessment services to clients across pharmaceuticals, biotech, medical devices, cosmetics, agri-foods, nutritional supplements, feed additives, and chemicals industries worldwide. Established in 2016, it operates with laboratories in Chennai, India.

Aragen Bioscience

Acquisition in 2014
Aragen Bioscience, Inc. is a preclinical contract research and development organization based in Morgan Hill, California. Founded in 2006, the company specializes in providing a comprehensive range of services for the pharmaceutical and biotechnology sectors. Its expertise includes recombinant cell line and hybridoma development, cell culture, protein purification, and the creation of primary and immortalized cell-based assays. Aragen also offers in vivo models of human disease and custom immunological services. The company’s capabilities extend to molecular biology, process development, protein chemistry, and hybridoma development, enabling the production of monoclonal antibodies and various therapeutic proteins. Additionally, Aragen conducts pharmacokinetic studies, pharmacology assessments, and functional analyses across multiple disease models. With a focus on supporting drug discovery and development, Aragen Bioscience plays a crucial role in advancing biomedical research.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.